
Impride PM 2mg/500mg/15mg Tablet SR
Marketer
Axis Life Science Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Impride PM 2mg/500mg/15mg Tablet SR
Diabetic patients with type 2 mellitus may find improved glycemic control through the use of Impride PM 2mg/500mg/15mg Tablet SR, a combined medication. This extended-release tablet, taken alongside a healthy diet and exercise regimen, enhances insulin effectiveness, reducing blood glucose. Dosage and frequency should strictly adhere to your physician's instructions; always take it with food to mitigate gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdose can result in hypoglycemia. Concurrent use with other antidiabetic medications, alcohol, or skipped meals elevates the hypoglycemia risk. Regular blood sugar monitoring is crucial. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Individuals with kidney, liver, or heart conditions should disclose this information to their doctor prior to commencing treatment, as should pregnant or lactating women. Pre-treatment kidney function assessment is standard. Limiting alcohol consumption is advisable to minimize potential adverse effects.
Uses of Impride PM 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Impride PM 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Impride PM 2mg/500mg/15mg Extended-Release tablet should be administered with a meal.
Common Side effects of Impride PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Impride PM 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Impride PM 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet with a meal.
How Impride PM 2mg/500mg/15mg Tablet SR works:
Impride PM SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts triply: it diminishes hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Impride PM 2mg/500mg/15mg SR tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Impride PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Impride PM tablets (2mg/500mg/15mg) are likely not suitable for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Impride PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates use of Impride PM 2mg/500mg/15mg SR tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking Impride PM 2mg/500mg/15mg SR tablets. Dosage modification may be necessary; physician consultation is advised. Impride PM 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Impride PM 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Impride PM 2mg/500mg/15mg Extended-Release Tablet, take it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Impride PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Medication for diabetes |
